Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders

Multiple Sclerosis Journal

Volumn 19, Issue 9, 2013, Pages 1216-1218

  Lim, Young Min ^a   Pyun, So Young ^a   Kang, Bong Hui ^a   Kim, Jimin ^a   Kim, Kwang Kuk ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

neuromyelitis optica spectrum disorders; neuromyelitis optica IgG; Plasma exchange; prognostic factors

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LABORATORY; MYELOOPTIC NEUROPATHY; PLASMAPHERESIS; SCHOOL CHILD; SPINAL CORD ATROPHY; TREATMENT RESPONSE;

NEUROMYELITIS OPTICA SPECTRUM DISORDERS; NEUROMYELITIS OPTICA-IGG; PLASMA EXCHANGE; PROGNOSTIC FACTORS;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELITIS, TRANSVERSE; NEUROMYELITIS OPTICA; PLASMA EXCHANGE; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84881037388     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512471875     Document Type: Article

References (10)

1. Weinshenker BG, O'Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999 ; 46: 878-886
2. Keegan M, Pineda AA, McClelland RL, et al. Plasma exchange for severe attacks of CNS demyelination: Predictors of response. Neurology. 2002 ; 58: 143-146
3. Watanabe S, Nakashima I, Misu T, et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler. 2007 ; 13: 128-132
4. Bonnan M, Valentino R, Olindo S, et al. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler. 2009 ; 15: 487-492
5. Llufriu S, Castillo J, Blanco Y, et al. Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months. Neurology. 2009 ; 73: 949-953
6. Magana SM, Keegan BM, Weinshenker BG, et al. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol. 2011 ; 68: 870-878
7. Wang KC, Wang SJ, Lee CL, et al. The rescue effect of plasma exchange for neuromyelitis optica. J Clin Neurosci. 2011 ; 18: 43-46
8. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489
9. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 ; 6: 805-815
10. Lennon V, Wingerchuk D, Kryzer T, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112